4.5 Article

Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults

Journal

INFECTIOUS DISEASES AND THERAPY
Volume 3, Issue 1, Pages 19-33

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s40121-014-0025-y

Keywords

Epidemiology; Infectious disease; Pneumococcal disease; Streptococcus pneumonia; United States; Veteran

Funding

  1. Office of Research and Development, Department of Veterans Affairs
  2. Advancing Science through Pfizer Initiated Research (ASPIRE) from Pfizer Inc.

Ask authors/readers for more resources

Introduction: Streptococcus pneumoniae is a major cause of morbidity and mortality. We sought to describe the epidemiology of noninvasive and invasive pneumococcal disease in a national Veterans Affairs population within the United States. Methods: We conducted a retrospective study in older patients (aged >= 50 years) with positive pneumococcal cultures from any site between 2002 and 2011. We described outpatient and inpatient pneumococcal disease incidence per 100,000 clinic visits/hospitalizations. Repeat cultures within a 30-day period were considered to represent the same episode. To describe the epidemiology of serious pneumococcal infections (bacteremia, meningitis, pneumonia), we assessed demographics, clinical characteristics, and risk factors for S. pneumoniae. Pneumonia was defined as a positive respiratory culture with a pneumonia diagnosis code. Bacteremia and meningitis were identified from positive cultures. Generalized linear mixed models were used to quantify changes over time. Results: Over the study period, we identified 45,983 unique episodes of pneumococcal disease (defined by positive cultures). Incidence decreased significantly by 3.5% per year in outpatients and increased nonsignificantly by 0.2% per year in inpatients. In 2011, the outpatient and inpatient incidence was 2.6 and 328.1 infections per 100,000 clinic visits/hospitalizations, respectively. Among inpatients with serious infections, chronic disease risk factors for pneumococcal disease increased significantly each year, including respiratory disease (1.9% (1.0%). Overall, 30.2% of inpatients with serious infections had a pneumococcal immunization in the previous 5 years. Invasive disease (37.4% versus 34.9%, P = 0.004) and mortality (14.0% versus 12.7%, P = 0.045) were higher in non-vaccinated patients compared to vaccinated patients. Conclusions: In our national study of older adults, the baseline health status of those with serious pneumococcal infections worsened over the study period. As the population ages and the chronic disease epidemic grows, the burden of pneumococcal disease is likely to increase thus highlighting the importance of pneumococcal vaccination.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available